Loading...

BRGH

DRG

BRIGHT MINDS BIOSCIENCES INC

(DRUG)

2025 6-K

6-K Filing Summary

13 Feb '26

Filing Overview

9 Jan '26

Funding Announcement

8 Jan '26

Company Filing Update

7 Jan '26

Equity Agreement Termination

7 Jan '26

Company Filing Update

6 Jan '26

Company Filing Update

6 Jan '26

Filing Update

5 Jan '26

Company Filing

17 Nov '25

Filing Amendment Update

17 Nov '25

Filing Summary

7 Nov '25

Company Filing

7 Nov '25

Filing Announcement

4 Sep '25

Financial Report Filing

14 Aug '25

Interim Financials Report

8 Aug '25

Filing Update

28 May '25

Company Filing Summary

20 May '25

Company Filing Update

13 May '25

Form 6-K Filing

28 Apr '25

Company Filing Update

4 Mar '25

Filing Submission

24 Feb '25

Financial Results Filed

13 Feb '25

Filings Announcement

7 Jan '25

Company Presentation Update

21 Nov '24

Private Placement Close

4 Nov '24

Filing Report

21 Oct '24

Filing Notification

18 Oct '24

Filing Date Confirmed

16 Oct '24

6-K Filing Summary

16 Oct '24

Filing Report

3 Oct '24

6-K Filing

12 Sep '24

Financial Report

14 Aug '24

Funding Report

16 May '24

AGM Notice Filed

16 May '24

Filing Summary

12 Feb '24

External Links:

SEC

Bright Minds Biosciences Inc. filed their 6-K report on August 14, 2025, detailing their condensed interim financial statements for the nine months ending June 30, 2025, and 2024, as well as management's analysis.

AI Assistant

BRIGHT MINDS BIOSCIENCES INC

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.